Hyaluronic Acid Market Size, Share & Trends Analysis Report By Application (Dermal Fillers, Osteoarthritis (Single Injection, Three Injection, Five Injection), Ophthalmic, Vesicoureteral Reflux) and By Region (U.S., Canada, Mexico, UK, France, Germany, Italy, Spain, Benelux Union, Nordic Countries , Rest of Europe, China, Japan, India, South Korea, Singapore, Philippines, Indonesia, Thailand, Malaysia, Vietnam, Rest of Southeast Asia, Brazil, Argentina Rest of Latin America, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Southern Africa, Rest of Middle East & Africa) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027
Industry Trends
Global Hyaluronic Acid Market was valued at US$ 8476.32 million in 2018 and is expected to reach US$ 14550.12 million by 2027, growing at an estimated CAGR of 6.2% over the forecast period.
Hyaluronic acid, also called as hyaluronan, is a viscous substance that is already present and produced in our body. Technically, it is naturally occurring glycosaminoglycan which is produced in human body and is circulated usually in epithelial, connective and neural tissues. By virtue of its viscosity, elasticity and other rheological properties, it acts as a lubricating and shock absorbing fluid in joints as well as ocular lubricant. This is mostly found in human eyes, skin and connective tissue. The main property of Hyaluronic acid is to maintain water and moisture in the tissues which results in keeping especially the skin, joints and eyes hydrated. It can hold a thousand times its weight in water, therefore skin feels and appears hydrated, plump and healthy. Research has shown that using eye drops containing hyaluronic acid helps to relieve symptoms of dry eye. Many doctors may use injection of hyaluronic acid into the joint to relieve joint pain and stiffness. The use of this is non-invasive and shows rapid results.
Increasing geriatric population and rising cases of obesity are expected to further expand the hyaluronic acid market over the forecast period. The hyaluronic acid combined with dermatan sulphate are used for treating cases of obesity. They can also be used in wide range of similar disorders such as, reducing and maintaining normal blood cholesterol levels and triglyceride levels, reducing body fat & fat formation.
There is rising population of women aged 35 to 65 across the world which gives rise to an increased demand for cosmetic, beauty & anti-aging treatments. Increasing requirements for antiaging solutions and cosmetic surgeries around the world coupled with tissue engineering and regenerative medicine are the propelling factors for the hyaluronic acid market. Majority of Hyaluronic acid (HA) in the body is in the skin where it plays a key role in the structuring of the tissue. With increasing age, HA decreases quite sharply in the skin, causing loss of volume in key areas, such as cheeks, under the eyes, jawline and around the mouth. Hyaluronic acid hydrates, and soothes dry skin when used in skin care. It acts as a humectant in our skin care regimen because of its ability to draw and hold water. This can reduce wrinkles and damage from the sun. Hyaluronic acid (HA) plays a multidimensional involvement in controlling the different biological processes, including skin recovery, wound healing, tissue regeneration, anti-inflammatory, and immunomodulation. It has been commonly used as one of the essential components of cosmetic and nutricosmetic products due to its extraordinary medicinal and tissue regeneration ability. The hyaluronic acid can come in gels, creams, intra-dermal filler injections, dermal fillers, facial fillers, autologous fat gels, lotion, serum, and implants and exhibit remarkable anti-nasolabial fold, anti-aging, space-filling, and face rejuvenating properties.
Application Outlook
In cosmetic industry, patients are delighted with the immediate correction of scars or rhytides. This can be achieved by using dermal fillers in the treatment. Dermal fillers are the most popular and nonsurgical injectable procedures. Belotero Balance, Juvederm Ultra, Juvederm Ultra Plus, Restylane, Restylane Silk, Restylane Lyft, and Voluma are the main types of dermal fillers that are used in wrinkle treatment and correcting soft tissue defects of the face. Hyaluronic acid-based dermal fillers are widely used to enhance nasolabial folds, eye lines, dark circles, cicatric remediation and rejuvenation. Injections of hyaluronic acid are easy to use, efficient and comparatively less costly. These related benefits are expected to drive the hyaluronic acid demand during the forecast period. To minimise the presence of of nasolabial folds and marionette lines, Juvederm Ultra, Juvederm Ultra Plus, Restylane, Restylane Lyft, and Belotero Balance are used. For fixing fine lines around the lips and adjusting lip volume or restructuring the shape of lips Belotero, Restylane Silk Juvederm Ultra are commonly used. Cheek augmentation which generally involves elevation of cheeks, cheeks restructure and reposition the cheek into a more youthful appearance is most widely perfomed with Voluma or Restylane Lyft. The effects and efficacy of the injection varies from patient to patient and are determined by the place of the injection, the particular properties of the hyaluronic acid filler, the patient's age and the actual skin characteristics.
Osteoarthritis (OA), a type of degenerative joint disease caused by wear and tear on the joints over time has affected millions of people worldwide. It is one of the diseases in which Hyaluronic acid is widely applied as it minimises the pain and stiffness in joints, slows the degeneration of cartilage and bone. This treatment is mostly used by patients who are unable to undergo total knee replacement surgery or cannot take pain killers medicines. The increase in geriatric population along with patient’s inclination towards minimally invasive procedures has boosted the hyaluronic acid market. Viscosupplementation is the procedure used in injecting Hyaluronic acid in the knee joint. The most recent research, however, has found viscosupplementation to be effective at significantly reducing pain or improving function of knee joints. The osteoarthritis segment is further bifurcated into three sections as single injection, three injection and five injection. Single-injection hyaluronic acids have been shown to have a similar effect in terms of pain relief and functional change to multiple-injection with significantly lower side effects risk. They are also cost effective as well as fast acting as compared with multi-injection hyaluronic acids. Thus, reducing visits to the doctors.
Hyaluronan (HA) is a biocompatible, naturally occurring polysaccharide with distinct viscoelastic and hygroscopic properties. It functions as a natural lubricant and its excellent water retention properties make it ideal for use in ophthalmic applications. It enhances hydration and lubrication of eyes. Applications such as cataract surgery, keratoplasty, trabeculectomy and retinal reattachment highly use hyaluronic acid in facilitating procedures and protecting the eyes post operations as well. Hyaluronic acid can be used in forms of eye drops in treatment of dry eyes as it acts as anti-inflammatory and improves tear conservation.
High product cost along with side effects of hyaluronic acid will restrict the growth of hyaluronic acid market. However, when using hyaluronic acid, people who have a history of severe allergic reactions, such as anaphylaxis, should be careful. The consequences like reactions or non-adaptability during pregnancy and while breastfeeding can be more. Hence, during these times women may want to avoid taking supplements with hyaluronic acid. Normal side effects for patients who receive injections containing hyaluronic acid may include experiences of pain, itching, bruising, swelling and redness. So, individuals should always do a patch test before starting to use a new skin product and take a prescription medication.
Geographical Outlook
Healthcare industry is expected to fuel customer demand in this area due to rapid adoption of new skin care treatments and technologies. These factors will drive the hyaluronic acid market in this region. In Europe, the Hyaluronic Acid Market will make a remarkable growth because the healthcare industry as well as cosmetic products are developed in terms of infrastructure and quality as the favourable regulatory environment and customers attraction towards effective treatment on obesity and osteoarthritis. Due to the growing geriatric population in Asia, which offers a large customer base for anti-aging products and services, Asia-Pacific is expected to emerge as the fastest-growing regional market during the projected period.
Global Hyaluronic Acid Market Market Revenue & Forecast, (US$ Million), 2015 – 2027
Competitive Landscape
Some key industry contributors to hyaluronic acid market are Allergan, Inc.; Galderma; Salix Pharmaceuticals; Lifecore Biomedical; Anika Therapeutics; Sanofi, Shiseido; Smith and Nephew Plc; LG Life Sciences; Maruha Nichiro, Inc.; Ferring Pharmaceutical; and Contipro. Market players are involved in R&D activities in order to introduce advanced and effective products. For instance, Anika Therapeutics, Inc. launched CINGAL in Europe in 2016. The company intended to make the product available in Germany, Poland, Italy, Czech Republic, and Hungary.
Hyaluronic Acid Market in Healthcare Market:
- Application Outlook
- Dermal fillers
- Osteoarthritis
- Single injection
- Three injection
- Five injection
- Ophthalmic
- Vesicoureteral reflux
- By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Global Hyaluronic Acid Market
6. Market Synopsis:
Global Hyaluronic Acid Market
7. Hyaluronic Acid Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Hyaluronic Acid Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Hyaluronic Acid Market
7.6. Porter’s
Five Force Analysis
8. Global Hyaluronic Acid Market Analysis and Forecasts, 2019 –
2027
8.1. Overview
8.1.1. Global
Hyaluronic Acid Market Revenue (US$ Mn)
8.2. Global
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
8.2.1. Dermal
fillers
8.2.1.1. Definition
8.2.1.2. Market
Estimation and Penetration, 2015 – 2018
8.2.1.3. Market
Forecast, 2019 – 2027
8.2.1.4. Compound
Annual Growth Rate (CAGR)
8.2.1.5. Regional
Bifurcation
8.2.1.5.1. North
America
8.2.1.5.1.1. Market
Estimation, 2015 – 2018
8.2.1.5.1.2. Market
Forecast, 2019 – 2027
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 – 2018
8.2.1.5.2.2. Market
Forecast, 2019 – 2027
8.2.1.5.3. Asia
Pacific
8.2.1.5.3.1. Market
Estimation, 2015 – 2018
8.2.1.5.3.2. Market
Forecast, 2019 – 2027
8.2.1.5.4. Middle
East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 – 2018
8.2.1.5.4.2. Market
Forecast, 2019 – 2027
8.2.1.5.5. Latin
America
8.2.1.5.5.1. Market
Estimation, 2015 – 2018
8.2.1.5.5.2. Market
Forecast, 2019 – 2027
8.2.2. Osteoarthritis
(Definition, Market Estimation and Penetration, 2015 – 2018, Market Estimation
(2015 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on Single injection, Three
injection, Five injection)
8.2.2.1. Single
injection
8.2.2.2. Three
injection
8.2.2.3. Five
injection
8.2.3. Ophthalmic
8.2.3.1. Definition
8.2.3.2. Market
Estimation and Penetration, 2015 – 2018
8.2.3.3. Market
Forecast, 2019 – 2027
8.2.3.4. Compound
Annual Growth Rate (CAGR)
8.2.3.5. Regional
Bifurcation
8.2.3.5.1. North
America
8.2.3.5.1.1. Market
Estimation, 2015 – 2018
8.2.3.5.1.2. Market
Forecast, 2019 – 2027
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 – 2018
8.2.3.5.2.2. Market
Forecast, 2019 – 2027
8.2.3.5.3. Asia
Pacific
8.2.3.5.3.1. Market
Estimation, 2015 – 2018
8.2.3.5.3.2. Market
Forecast, 2019 – 2027
8.2.3.5.4. Middle
East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 – 2018
8.2.3.5.4.2. Market
Forecast, 2019 – 2027
8.2.3.5.5. Latin
America
8.2.3.5.5.1. Market
Estimation, 2015 – 2018
8.2.3.5.5.2. Market
Forecast, 2019 – 2027
8.2.4. Vesicoureteral
reflux
8.2.4.1. Definition
8.2.4.2. Market
Estimation and Penetration, 2015 – 2018
8.2.4.3. Market
Forecast, 2019 – 2027
8.2.4.4. Compound
Annual Growth Rate (CAGR)
8.2.4.5. Regional
Bifurcation
8.2.4.5.1. North
America
8.2.4.5.1.1. Market
Estimation, 2015 – 2018
8.2.4.5.1.2. Market
Forecast, 2019 – 2027
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 – 2018
8.2.4.5.2.2. Market
Forecast, 2019 – 2027
8.2.4.5.3. Asia
Pacific
8.2.4.5.3.1. Market
Estimation, 2015 – 2018
8.2.4.5.3.2. Market
Forecast, 2019 – 2027
8.2.4.5.4. Middle
East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 – 2018
8.2.4.5.4.2. Market
Forecast, 2019 – 2027
8.2.4.5.5. Latin
America
8.2.4.5.5.1. Market
Estimation, 2015 – 2018
8.2.4.5.5.2. Market
Forecast, 2019 – 2027
8.2.5. Others
8.2.5.1. Definition
8.2.5.2. Market
Estimation and Penetration, 2015 – 2018
8.2.5.3. Market
Forecast, 2019 – 2027
8.2.5.4. Compound
Annual Growth Rate (CAGR)
8.2.5.5. Regional
Bifurcation
8.2.5.5.1. North
America
8.2.5.5.1.1. Market
Estimation, 2015 – 2018
8.2.5.5.1.2. Market
Forecast, 2019 – 2027
8.2.5.5.2. Europe
8.2.5.5.2.1. Market
Estimation, 2015 – 2018
8.2.5.5.2.2. Market
Forecast, 2019 – 2027
8.2.5.5.3. Asia
Pacific
8.2.5.5.3.1. Market
Estimation, 2015 – 2018
8.2.5.5.3.2. Market
Forecast, 2019 – 2027
8.2.5.5.4. Middle
East and Africa
8.2.5.5.4.1. Market
Estimation, 2015 – 2018
8.2.5.5.4.2. Market
Forecast, 2019 – 2027
8.2.5.5.5. Latin
America
8.2.5.5.5.1. Market
Estimation, 2015 – 2018
8.2.5.5.5.2. Market
Forecast, 2019 – 2027
8.3. Key
Segment for Channeling Investments
8.3.1. By
Application
9. North America Hyaluronic Acid Market Analysis and Forecasts,
2019 - 2027
9.1. Overview
9.1.1. North
America Hyaluronic Acid Market Revenue (US$ Mn)
9.2. North
America Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
9.2.1. Dermal
fillers
9.2.2. Osteoarthritis
9.2.2.1. Single
injection
9.2.2.2. Three
injection
9.2.2.3. Five
injection
9.2.3. Ophthalmic
9.2.4. Vesicoureteral
reflux
9.2.5. Others
9.3. North
America Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Country
9.3.1. U.S
9.3.1.1. U.S
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
9.3.1.1.1. Dermal
fillers
9.3.1.1.2. Osteoarthritis
9.3.1.1.2.1. Single
injection
9.3.1.1.2.2. Three
injection
9.3.1.1.2.3. Five
injection
9.3.1.1.3. Ophthalmic
9.3.1.1.4. Vesicoureteral
reflux
9.3.1.1.5. Others
9.3.2. Canada
9.3.2.1. Canada
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
9.3.2.1.1. Dermal
fillers
9.3.2.1.2. Osteoarthritis
9.3.2.1.2.1. Single
injection
9.3.2.1.2.2. Three
injection
9.3.2.1.2.3. Five
injection
9.3.2.1.3. Ophthalmic
9.3.2.1.4. Vesicoureteral
reflux
9.3.2.1.5. Others
9.3.3. Mexico
9.3.3.1. Mexico
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
9.3.3.1.1. Dermal
fillers
9.3.3.1.2. Osteoarthritis
9.3.3.1.2.1. Single
injection
9.3.3.1.2.2. Three
injection
9.3.3.1.2.3. Five
injection
9.3.3.1.3. Ophthalmic
9.3.3.1.4. Vesicoureteral
reflux
9.3.3.1.5. Others
9.3.4. Rest of
North America
9.3.4.1. Rest
of North America Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By
Application
9.3.4.1.1. Dermal
fillers
9.3.4.1.2. Osteoarthritis
9.3.4.1.2.1. Single
injection
9.3.4.1.2.2. Three
injection
9.3.4.1.2.3. Five
injection
9.3.4.1.3. Ophthalmic
9.3.4.1.4. Vesicoureteral
reflux
9.3.4.1.5. Others
9.4. Key
Segment for Channeling Investments
9.4.1. By
Country
9.4.2. By
Application
10. Europe Hyaluronic Acid Market Analysis and Forecasts, 2019 -
2027
10.1. Overview
10.1.1. Europe
Hyaluronic Acid Market Revenue (US$ Mn)
10.2. Europe
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
10.2.1. Dermal
fillers
10.2.2. Osteoarthritis
10.2.2.1. Single
injection
10.2.2.2. Three
injection
10.2.2.3. Five
injection
10.2.3. Ophthalmic
10.2.4. Vesicoureteral
reflux
10.2.5. Others
10.3. Europe
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Country
10.3.1. France
10.3.1.1. France
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
10.3.1.1.1. Dermal
fillers
10.3.1.1.2. Osteoarthritis
10.3.1.1.2.1. Single
injection
10.3.1.1.2.2. Three
injection
10.3.1.1.2.3. Five
injection
10.3.1.1.3. Ophthalmic
10.3.1.1.4. Vesicoureteral
reflux
10.3.1.1.5. Others
10.3.2. The UK
10.3.2.1. The
UK Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
10.3.2.1.1. Dermal
fillers
10.3.2.1.2. Osteoarthritis
10.3.2.1.2.1. Single
injection
10.3.2.1.2.2. Three
injection
10.3.2.1.2.3. Five
injection
10.3.2.1.3. Ophthalmic
10.3.2.1.4. Vesicoureteral
reflux
10.3.2.1.5. Others
10.3.3. Spain
10.3.3.1. Spain
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
10.3.3.1.1. Dermal
fillers
10.3.3.1.2. Osteoarthritis
10.3.3.1.2.1. Single
injection
10.3.3.1.2.2. Three
injection
10.3.3.1.2.3. Five
injection
10.3.3.1.3. Ophthalmic
10.3.3.1.4. Vesicoureteral
reflux
10.3.3.1.5. Others
10.3.4. Germany
10.3.4.1. Germany
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
10.3.4.1.1. Dermal
fillers
10.3.4.1.2. Osteoarthritis
10.3.4.1.2.1. Single
injection
10.3.4.1.2.2. Three
injection
10.3.4.1.2.3. Five
injection
10.3.4.1.3. Ophthalmic
10.3.4.1.4. Vesicoureteral
reflux
10.3.4.1.5. Others
10.3.5. Italy
10.3.5.1. Italy
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
10.3.5.1.1. Dermal
fillers
10.3.5.1.2. Osteoarthritis
10.3.5.1.2.1. Single
injection
10.3.5.1.2.2. Three
injection
10.3.5.1.2.3. Five
injection
10.3.5.1.3. Ophthalmic
10.3.5.1.4. Vesicoureteral
reflux
10.3.5.1.5. Others
10.3.6. Nordic
Countries
10.3.6.1. Nordic
Countries Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
10.3.6.1.1. Dermal
fillers
10.3.6.1.2. Osteoarthritis
10.3.6.1.2.1. Single
injection
10.3.6.1.2.2. Three
injection
10.3.6.1.2.3. Five
injection
10.3.6.1.3. Ophthalmic
10.3.6.1.4. Vesicoureteral
reflux
10.3.6.1.5. Others
10.3.6.2. Nordic
Countries Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Country
10.3.6.2.1. Denmark
10.3.6.2.2. Finland
10.3.6.2.3. Iceland
10.3.6.2.4. Sweden
10.3.6.2.5. Norway
10.3.7. Benelux
Union
10.3.7.1. Benelux
Union Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
10.3.7.1.1. Dermal
fillers
10.3.7.1.2. Osteoarthritis
10.3.7.1.2.1. Single
injection
10.3.7.1.2.2. Three
injection
10.3.7.1.2.3. Five
injection
10.3.7.1.3. Ophthalmic
10.3.7.1.4. Vesicoureteral
reflux
10.3.7.1.5. Others
10.3.7.2. Benelux
Union Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Country
10.3.7.2.1. Belgium
10.3.7.2.2. The
Netherlands
10.3.7.2.3. Luxembourg
10.3.8. Rest of
Europe
10.3.8.1. Rest
of Europe Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
10.3.8.1.1. Dermal
fillers
10.3.8.1.2. Osteoarthritis
10.3.8.1.2.1. Single
injection
10.3.8.1.2.2. Three
injection
10.3.8.1.2.3. Five
injection
10.3.8.1.3. Ophthalmic
10.3.8.1.4. Vesicoureteral
reflux
10.3.8.1.5. Others
10.4. Key
Segment for Channeling Investments
10.4.1. By
Country
10.4.2. By
Application
11. Asia Pacific Hyaluronic Acid Market Analysis and Forecasts,
2019 - 2027
11.1. Overview
11.1.1. Asia
Pacific Hyaluronic Acid Market Revenue (US$ Mn)
11.2. Asia
Pacific Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
11.2.1. Dermal
fillers
11.2.2. Osteoarthritis
11.2.2.1. Single
injection
11.2.2.2. Three
injection
11.2.2.3. Five
injection
11.2.3. Ophthalmic
11.2.4. Vesicoureteral
reflux
11.2.5. Others
11.3. Asia
Pacific Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Country
11.3.1. China
11.3.1.1. China
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
11.3.1.1.1. Dermal
fillers
11.3.1.1.2. Osteoarthritis
11.3.1.1.2.1. Single
injection
11.3.1.1.2.2. Three
injection
11.3.1.1.2.3. Five
injection
11.3.1.1.3. Ophthalmic
11.3.1.1.4. Vesicoureteral
reflux
11.3.1.1.5. Others
11.3.2. Japan
11.3.2.1. Japan
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
11.3.2.1.1. Dermal
fillers
11.3.2.1.2. Osteoarthritis
11.3.2.1.2.1. Single
injection
11.3.2.1.2.2. Three
injection
11.3.2.1.2.3. Five
injection
11.3.2.1.3. Ophthalmic
11.3.2.1.4. Vesicoureteral
reflux
11.3.2.1.5. Others
11.3.3. India
11.3.3.1. India
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
11.3.3.1.1. Dermal
fillers
11.3.3.1.2. Osteoarthritis
11.3.3.1.2.1. Single
injection
11.3.3.1.2.2. Three
injection
11.3.3.1.2.3. Five
injection
11.3.3.1.3. Ophthalmic
11.3.3.1.4. Vesicoureteral
reflux
11.3.3.1.5. Others
11.3.4. New
Zealand
11.3.4.1. New
Zealand Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
11.3.4.1.1. Dermal
fillers
11.3.4.1.2. Osteoarthritis
11.3.4.1.2.1. Single
injection
11.3.4.1.2.2. Three
injection
11.3.4.1.2.3. Five
injection
11.3.4.1.3. Ophthalmic
11.3.4.1.4. Vesicoureteral
reflux
11.3.4.1.5. Others
11.3.5. Australia
11.3.5.1. Australia
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
11.3.5.1.1. Dermal
fillers
11.3.5.1.2. Osteoarthritis
11.3.5.1.2.1. Single
injection
11.3.5.1.2.2. Three
injection
11.3.5.1.2.3. Five
injection
11.3.5.1.3. Ophthalmic
11.3.5.1.4. Vesicoureteral
reflux
11.3.5.1.5. Others
11.3.6. South
Korea
11.3.6.1. South
Korea Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
11.3.6.1.1. Dermal
fillers
11.3.6.1.2. Osteoarthritis
11.3.6.1.2.1. Single
injection
11.3.6.1.2.2. Three
injection
11.3.6.1.2.3. Five
injection
11.3.6.1.3. Ophthalmic
11.3.6.1.4. Vesicoureteral
reflux
11.3.6.1.5. Others
11.3.7. Southeast
Asia
11.3.7.1. Southeast
Asia Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
11.3.7.1.1. Dermal
fillers
11.3.7.1.2. Osteoarthritis
11.3.7.1.2.1. Single
injection
11.3.7.1.2.2. Three
injection
11.3.7.1.2.3. Five
injection
11.3.7.1.3. Ophthalmic
11.3.7.1.4. Vesicoureteral
reflux
11.3.7.1.5. Others
11.3.7.2. Southeast
Asia Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Country
11.3.7.2.1. Indonesia
11.3.7.2.2. Thailand
11.3.7.2.3. Malaysia
11.3.7.2.4. Singapore
11.3.7.2.5. Rest
of Southeast Asia
11.3.8. Rest of
Asia Pacific
11.3.8.1. Rest
of Asia Pacific Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By
Application
11.3.8.1.1. Dermal
fillers
11.3.8.1.2. Osteoarthritis
11.3.8.1.2.1. Single
injection
11.3.8.1.2.2. Three
injection
11.3.8.1.2.3. Five
injection
11.3.8.1.3. Ophthalmic
11.3.8.1.4. Vesicoureteral
reflux
11.3.8.1.5. Others
11.4. Key
Segment for Channeling Investments
11.4.1. By
Country
11.4.2. By
Application
12. Middle East and Africa Hyaluronic Acid Market Analysis and
Forecasts, 2019 - 2027
12.1. Overview
12.1.1. Middle
East and Africa Hyaluronic Acid Market Revenue (US$ Mn)
12.2. Middle
East and Africa Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By
Application
12.2.1. Dermal
fillers
12.2.2. Osteoarthritis
12.2.2.1. Single
injection
12.2.2.2. Three
injection
12.2.2.3. Five
injection
12.2.3. Ophthalmic
12.2.4. Vesicoureteral
reflux
12.2.5. Others
12.3. Middle
East and Africa Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By
Country
12.3.1. Saudi
Arabia
12.3.1.1. Saudi
Arabia Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
12.3.1.1.1. Dermal
fillers
12.3.1.1.2. Osteoarthritis
12.3.1.1.2.1. Single
injection
12.3.1.1.2.2. Three
injection
12.3.1.1.2.3. Five
injection
12.3.1.1.3. Ophthalmic
12.3.1.1.4. Vesicoureteral
reflux
12.3.1.1.5. Others
12.3.2. UAE
12.3.2.1. UAE
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
12.3.2.1.1. Dermal
fillers
12.3.2.1.2. Osteoarthritis
12.3.2.1.2.1. Single
injection
12.3.2.1.2.2. Three
injection
12.3.2.1.2.3. Five
injection
12.3.2.1.3. Ophthalmic
12.3.2.1.4. Vesicoureteral
reflux
12.3.2.1.5. Others
12.3.3. Egypt
12.3.3.1. Egypt
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
12.3.3.1.1. Dermal
fillers
12.3.3.1.2. Osteoarthritis
12.3.3.1.2.1. Single
injection
12.3.3.1.2.2. Three
injection
12.3.3.1.2.3. Five
injection
12.3.3.1.3. Ophthalmic
12.3.3.1.4. Vesicoureteral
reflux
12.3.3.1.5. Others
12.3.4. Kuwait
12.3.4.1. Kuwait
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
12.3.4.1.1. Dermal
fillers
12.3.4.1.2. Osteoarthritis
12.3.4.1.2.1. Single
injection
12.3.4.1.2.2. Three
injection
12.3.4.1.2.3. Five
injection
12.3.4.1.3. Ophthalmic
12.3.4.1.4. Vesicoureteral
reflux
12.3.4.1.5. Others
12.3.5. South
Africa
12.3.5.1. South
Africa Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
12.3.5.1.1. Dermal
fillers
12.3.5.1.2. Osteoarthritis
12.3.5.1.2.1. Single
injection
12.3.5.1.2.2. Three
injection
12.3.5.1.2.3. Five
injection
12.3.5.1.3. Ophthalmic
12.3.5.1.4. Vesicoureteral
reflux
12.3.5.1.5. Others
12.3.6. Rest of
Middle East & Africa
12.3.6.1. Rest
of Middle East & Africa Hyaluronic Acid Market Revenue (US$ Mn) and
Forecasts, By Application
12.3.6.1.1. Dermal
fillers
12.3.6.1.2. Osteoarthritis
12.3.6.1.2.1. Single
injection
12.3.6.1.2.2. Three
injection
12.3.6.1.2.3. Five
injection
12.3.6.1.3. Ophthalmic
12.3.6.1.4. Vesicoureteral
reflux
12.3.6.1.5. Others
12.4. Key
Segment for Channeling Investments
12.4.1. By
Country
12.4.2. By
Application
13. Latin America Hyaluronic Acid Market Analysis and Forecasts,
2019 - 2027
13.1. Overview
13.1.1. Latin America
Hyaluronic Acid Market Revenue (US$ Mn)
13.2. Latin
America Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
13.2.1. Dermal
fillers
13.2.2. Osteoarthritis
13.2.2.1. Single
injection
13.2.2.2. Three
injection
13.2.2.3. Five
injection
13.2.3. Ophthalmic
13.2.4. Vesicoureteral
reflux
13.2.5. Others
13.3. Latin
America Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Country
13.3.1. Brazil
13.3.1.1. Brazil
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
13.3.1.1.1. Dermal
fillers
13.3.1.1.2. Osteoarthritis
13.3.1.1.2.1. Single
injection
13.3.1.1.2.2. Three
injection
13.3.1.1.2.3. Five
injection
13.3.1.1.3. Ophthalmic
13.3.1.1.4. Vesicoureteral
reflux
13.3.1.1.5. Others
13.3.2. Argentina
13.3.2.1. Argentina
Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By Application
13.3.2.1.1. Dermal
fillers
13.3.2.1.2. Osteoarthritis
13.3.2.1.2.1. Single
injection
13.3.2.1.2.2. Three
injection
13.3.2.1.2.3. Five
injection
13.3.2.1.3. Ophthalmic
13.3.2.1.4. Vesicoureteral
reflux
13.3.2.1.5. Others
13.3.3. Rest of
Latin America
13.3.3.1. Rest
of Latin America Hyaluronic Acid Market Revenue (US$ Mn) and Forecasts, By
Application
13.3.3.1.1. Dermal
fillers
13.3.3.1.2. Osteoarthritis
13.3.3.1.2.1. Single
injection
13.3.3.1.2.2. Three
injection
13.3.3.1.2.3. Five
injection
13.3.3.1.3. Ophthalmic
13.3.3.1.4. Vesicoureteral
reflux
13.3.3.1.5. Others
13.4. Key
Segment for Channeling Investments
13.4.1. By Country
13.4.2. By
Application
14. Competitive Benchmarking
14.1. Market
Share Analysis, 2018
14.2. Global
Presence and Growth Strategies
14.2.1. Mergers
and Acquisitions
14.2.2. Product
Launches
14.2.3. Investments
Trends
14.2.4. R&D
Initiatives
15. Player Profiles
15.1. Allergan,
Inc
15.1.1. Company
Details
15.1.2. Company
Overview
15.1.3. Product
Offerings
15.1.4. Key
Developments
15.1.5. Financial
Analysis
15.1.6. SWOT
Analysis
15.1.7. Business
Strategies
15.2. Galderma
15.2.1. Company
Details
15.2.2. Company
Overview
15.2.3. Product
Offerings
15.2.4. Key
Developments
15.2.5. Financial
Analysis
15.2.6. SWOT
Analysis
15.2.7. Business
Strategies
15.3. Salix
Pharmaceuticals
15.3.1. Company
Details
15.3.2. Company
Overview
15.3.3. Product
Offerings
15.3.4. Key
Developments
15.3.5. Financial
Analysis
15.3.6. SWOT
Analysis
15.3.7. Business
Strategies
15.4. Lifecore
Biomedical
15.4.1. Company
Details
15.4.2. Company
Overview
15.4.3. Product
Offerings
15.4.4. Key
Developments
15.4.5. Financial
Analysis
15.4.6. SWOT
Analysis
15.4.7. Business
Strategies
15.5. Anika Therapeutics
15.5.1. Company
Details
15.5.2. Company
Overview
15.5.3. Product
Offerings
15.5.4. Key
Developments
15.5.5. Financial
Analysis
15.5.6. SWOT
Analysis
15.5.7. Business
Strategies
15.6. Sanofi,
Shiseido
15.6.1. Company
Details
15.6.2. Company
Overview
15.6.3. Product
Offerings
15.6.4. Key
Developments
15.6.5. Financial
Analysis
15.6.6. SWOT
Analysis
15.6.7. Business
Strategies
15.7. Smith and
Nephew Plc
15.7.1. Company
Details
15.7.2. Company
Overview
15.7.3. Product
Offerings
15.7.4. Key
Developments
15.7.5. Financial
Analysis
15.7.6. SWOT
Analysis
15.7.7. Business
Strategies
15.8. LG Life
Sciences
15.8.1. Company
Details
15.8.2. Company
Overview
15.8.3. Product
Offerings
15.8.4. Key
Developments
15.8.5. Financial
Analysis
15.8.6. SWOT
Analysis
15.8.7. Business
Strategies
15.9. Maruha
Nichiro, Inc
15.9.1. Company
Details
15.9.2. Company
Overview
15.9.3. Product
Offerings
15.9.4. Key
Developments
15.9.5. Financial
Analysis
15.9.6. SWOT
Analysis
15.9.7. Business
Strategies
15.10. Ferring
Pharmaceutical
15.10.1. Company
Details
15.10.2. Company
Overview
15.10.3. Product
Offerings
15.10.4. Key
Developments
15.10.5. Financial
Analysis
15.10.6. SWOT
Analysis
15.10.7. Business
Strategies
15.11. Contipro
15.11.1. Company
Details
15.11.2. Company
Overview
15.11.3. Product
Offerings
15.11.4. Key
Developments
15.11.5. Financial
Analysis
15.11.6. SWOT
Analysis
15.11.7. Business
Strategies
15.12. Other
Market Participants
16. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.